What Caught Our Attention in the Investment World? – Week of March 28-April 1, 2022

By Kuldip K. Ambastha Longeveron Inc. (LGVN), a biotechnology company focused on clinical stage therapies, had its stock price rise by +105.4% per share on Thursday, March 31, 2022. On this trading day, a great piece of news led to a great return. Lomecel-B has shown positive results from its Phase 1 trial testing on …

What Caught Our Attention in the Investment World? – Week of June 7-11, 2021

By Kuldip K. Ambastha Biogen Inc. (BIIB), a biotech company, had a memorable Monday of this past trading week. On Monday, June 7, 2021, Biogen had a +38.3% gain for the day on its stock. Biogen’s Alzheimer’s disease treatment was approved by the U.S. Food and Drug Administration (FDA) as part of an accelerated approval …